Glass Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.79M Buy
5,001
+553
+12% +$653K 1.83% 19
2026
Q2
$5.34M Buy
4,448
+358
+9% +$366K 1.79% 18
2026
Q1
$3.76M Buy
4,090
+230
+6% +$233K 1.46% 24
2025
Q4
$4.15M Buy
3,860
+464
+14% +$444K 1.7% 22
2025
Q3
$2.59M Buy
3,396
+520
+18% +$387K 1.16% 28
2025
Q2
$2.24M Buy
2,876
+92
+3% +$71.5K 1.19% 30
2025
Q1
$2.3M Buy
2,784
+95
+4% +$79K 1.38% 26
2024
Q4
$2.08M Buy
2,689
+380
+16% +$315K 1.13% 34
2024
Q3
$2.05M Buy
2,309
+680
+42% +$611K 1.13% 35
2024
Q2
$1.47M Buy
1,629
+612
+60% +$490K 0.86% 40
2024
Q1
$791K Buy
+1,017
New +$724K 0.48% 46

Other funds holding LLY

Glass Wealth Management's LLY Position: Q3 2026 in Review

Glass Wealth Management increased its Eli Lilly (LLY) stake by 12% in Q3 2026, buying an estimated $653K and bringing the position to 5,001 shares worth $5.79M. The position accounts for 1.83% of the portfolio, ranked #19.

Glass Wealth Management first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. 3,679 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Glass Wealth Management held 5,001 shares of Eli Lilly worth $5.79M as of Q3 2026.
  • Glass Wealth Management bought 553 Eli Lilly shares in Q3 2026, an estimated $653K.
  • Eli Lilly made up 1.83% of Glass Wealth Management's portfolio in Q3 2026, its #19 holding.
  • Glass Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
  • 3,679 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Glass Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.